Skip to main content

Table 2 Summaries of pooled depression prevalence grouped by screening criteria and thresholds used

From: The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis

 

Quality-effects model

Random-effects model

Sensitivity analysis

Pooled prevalence

95% CI, I2

Pooled prevalence

95% CI, I2

Pooled prevalence

95% CI, I2

All studies

HADS (≥ 7/8)

38%

30 to 45%, I2 = 85%

40%

47 to 33%, I2 = 85%

36%

30 to 42%, I2 = 77%

HADS (≥ 11)

15%

6 to 25%, I2 = 89%

17%

11 to 24%, I2 = 89%

14%

12 to 15%, I2 = 0%

SDS

52%

29 to 75%, I2 = 96%

41%

26 to 58%, I2 = 96%

36%

31 to 40%, I2 = 13%

AS

HADS (≥ 7/8)

38%

28 to 48%, I2 = 86%

38%

28 to 48%, I2 = 86%

36%

28 to 45%, I2 = 79%

HADS (≥ 11)

18%

3 to 36%, I2 = 94%

18%

3 to 36%, I2 = 94%

11%

8 to 15%, I2 = 0%

SDS

52%

28 to 76%, I2 = 96%

41%

25 to 58%, I2 = 96%

35%

31 to 39%, I2 = 0%

nr-axSpA

HADS (≥ 7/8)

36%

27 to 46%, I2 = 71%

36%

27 to 46%, I2 = 71%

NA

NA

  1. Estimates were presented by quality-effects model, random-effects model, and sensitivity analysis excluding the studies by Hakkou et al. and Jiang et al.
  2. HADS Hospital Anxiety and Depression Scale—depression subscale, SDS Zung self-rating depression scale, AS ankylosing spondylitis, axSpA axial spondyloarthritis, nr-axSpA non-radiographic axSpA, NA not applicable
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us